Share Price and Basic Stock Data
Last Updated: December 24, 2025, 8:38 pm
| PEG Ratio | 4.23 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
CRISIL Ltd operates in the services sector, primarily focusing on providing ratings, research, risk, and policy advisory services. The company reported a market capitalization of ₹31,058 Cr and a share price of ₹4,247. Revenue from operations has shown a consistent upward trend, standing at ₹3,140 Cr for the year ending December 2023, up from ₹2,769 Cr in December 2022. The revenue growth trajectory is robust, with trailing twelve months (TTM) revenue reaching ₹3,480 Cr. Quarterly sales figures reflect this momentum, with the latest reported sales in December 2023 at ₹918 Cr, following a steady rise from ₹669 Cr in June 2022. This sustained revenue growth underscores CRISIL’s strong market positioning and operational effectiveness in an increasingly competitive landscape.
Profitability and Efficiency Metrics
CRISIL’s profitability metrics are noteworthy, with a reported net profit of ₹749 Cr for the TTM, translating to an impressive net profit margin of 20.98% in December 2024. The operating profit margin (OPM) also stood strong at 28%, reflecting the company’s ability to maintain cost efficiencies while driving revenue. Return on equity (ROE) was recorded at 27.8%, while return on capital employed (ROCE) reached 35.6%, indicating effective utilization of capital to generate earnings. The interest coverage ratio (ICR) was exceptionally high at 248.25x, showcasing CRISIL’s robust ability to cover interest obligations. However, the cash conversion cycle (CCC) increased to 62 days in December 2024, suggesting potential challenges in managing receivables and cash flows that need addressing to sustain profitability.
Balance Sheet Strength and Financial Ratios
CRISIL’s balance sheet reflects a solid financial foundation, with total assets reported at ₹4,231 Cr as of June 2025. The company has maintained reserves of ₹2,809 Cr, which bolsters its equity capital of ₹7 Cr. However, borrowings have risen to ₹298 Cr, up from ₹83 Cr in December 2022, indicating a strategic decision to leverage debt for growth. The price-to-book value (P/BV) ratio stood at 19.05x, suggesting that the stock is trading at a premium compared to its book value, which was ₹350.86 per share at the end of December 2024. The current ratio of 1.96x and quick ratio of 1.96x signify adequate liquidity to meet short-term liabilities. Although CRISIL’s financial ratios indicate a healthy financial position, the increasing leverage may pose risks if not managed prudently.
Shareholding Pattern and Investor Confidence
The shareholding pattern of CRISIL indicates strong promoter confidence, with promoters holding 66.64% of the equity as of June 2025. This stable ownership structure can foster long-term strategic direction and operational stability. Foreign institutional investors (FIIs) hold 7.81%, while domestic institutional investors (DIIs) account for 12.17%, reflecting a balanced mix of institutional interest. The total number of shareholders has increased significantly to 74,565, up from 54,551 in December 2022, indicating growing investor interest and confidence in the company. However, the declining percentage of DII holdings from 13.03% in December 2022 to 12.06% in June 2025 may raise concerns about domestic institutional support, which could influence market sentiment and stock performance in the long term.
Outlook, Risks, and Final Insight
Looking ahead, CRISIL is well-positioned to leverage its market leadership in the services sector, backed by strong profitability metrics and a solid balance sheet. However, potential risks include increasing leverage due to rising borrowings, which could impact financial stability if not managed effectively. Additionally, the higher cash conversion cycle may strain liquidity and operational efficiency. The company must focus on improving receivables management to mitigate these risks. If CRISIL can navigate these challenges while sustaining its growth momentum, it has the potential to enhance shareholder value significantly. Conversely, failure to address these risks could hinder its operational effectiveness and investor confidence. Overall, CRISIL’s prospects remain positive, contingent upon its strategic initiatives and market conditions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IMEC Services Ltd | 54.0 Cr. | 284 | 448/54.2 | 2.19 | 138 | 0.00 % | 177 % | 177 % | 10.0 |
| Focus Business Solution Ltd | 106 Cr. | 145 | 145/50.6 | 89.4 | 11.1 | 0.04 % | 15.5 % | 12.4 % | 10.0 |
| EKI Energy Services Ltd | 263 Cr. | 95.2 | 294/82.4 | 34.1 | 154 | 2.10 % | 3.93 % | 3.46 % | 10.0 |
| CMS Info Systems Ltd | 5,749 Cr. | 349 | 541/340 | 17.9 | 135 | 1.86 % | 21.8 % | 15.7 % | 10.0 |
| Ashram Online.Com Ltd | 6.32 Cr. | 5.27 | 6.48/4.11 | 10.5 | 0.00 % | 0.32 % | 0.57 % | 10.0 | |
| Industry Average | 11,297.40 Cr | 560.11 | 38.35 | 147.49 | 0.60% | 21.57% | 19.94% | 8.65 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 669 | 683 | 822 | 715 | 771 | 736 | 918 | 738 | 797 | 812 | 913 | 813 | 843 |
| Expenses | 499 | 531 | 606 | 511 | 567 | 544 | 649 | 546 | 591 | 588 | 626 | 581 | 604 |
| Operating Profit | 169 | 151 | 216 | 203 | 204 | 192 | 269 | 192 | 207 | 224 | 287 | 232 | 239 |
| OPM % | 25% | 22% | 26% | 28% | 26% | 26% | 29% | 26% | 26% | 28% | 31% | 29% | 28% |
| Other Income | 35 | 65 | 18 | 17 | 18 | 36 | 36 | 21 | 18 | 21 | 30 | 31 | 24 |
| Interest | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 6 | 6 |
| Depreciation | 26 | 26 | 26 | 26 | 26 | 26 | 25 | 17 | 16 | 16 | 21 | 30 | 32 |
| Profit before tax | 177 | 189 | 207 | 194 | 195 | 200 | 279 | 195 | 208 | 229 | 294 | 227 | 225 |
| Tax % | 23% | 22% | 24% | 25% | 23% | 24% | 25% | 30% | 28% | 25% | 24% | 30% | 24% |
| Net Profit | 137 | 148 | 158 | 146 | 151 | 152 | 210 | 138 | 150 | 172 | 225 | 160 | 172 |
| EPS in Rs | 18.75 | 20.24 | 21.63 | 19.94 | 20.60 | 20.79 | 28.74 | 18.84 | 20.53 | 23.46 | 30.72 | 21.86 | 23.46 |
Last Updated: August 1, 2025, 10:30 pm
Below is a detailed analysis of the quarterly data for CRISIL Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 843.00 Cr.. The value appears strong and on an upward trend. It has increased from 813.00 Cr. (Mar 2025) to 843.00 Cr., marking an increase of 30.00 Cr..
- For Expenses, as of Jun 2025, the value is 604.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 581.00 Cr. (Mar 2025) to 604.00 Cr., marking an increase of 23.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 239.00 Cr.. The value appears strong and on an upward trend. It has increased from 232.00 Cr. (Mar 2025) to 239.00 Cr., marking an increase of 7.00 Cr..
- For OPM %, as of Jun 2025, the value is 28.00%. The value appears to be declining and may need further review. It has decreased from 29.00% (Mar 2025) to 28.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 24.00 Cr.. The value appears to be declining and may need further review. It has decreased from 31.00 Cr. (Mar 2025) to 24.00 Cr., marking a decrease of 7.00 Cr..
- For Interest, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
- For Depreciation, as of Jun 2025, the value is 32.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 225.00 Cr.. The value appears to be declining and may need further review. It has decreased from 227.00 Cr. (Mar 2025) to 225.00 Cr., marking a decrease of 2.00 Cr..
- For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 30.00% (Mar 2025) to 24.00%, marking a decrease of 6.00%.
- For Net Profit, as of Jun 2025, the value is 172.00 Cr.. The value appears strong and on an upward trend. It has increased from 160.00 Cr. (Mar 2025) to 172.00 Cr., marking an increase of 12.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 23.46. The value appears strong and on an upward trend. It has increased from 21.86 (Mar 2025) to 23.46, marking an increase of 1.60.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:28 am
| Metric | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,111 | 1,253 | 1,380 | 1,548 | 1,658 | 1,748 | 1,732 | 1,982 | 2,301 | 2,769 | 3,140 | 3,260 | 3,480 |
| Expenses | 750 | 865 | 980 | 1,104 | 1,203 | 1,277 | 1,276 | 1,471 | 1,690 | 2,039 | 2,258 | 2,349 | 2,459 |
| Operating Profit | 361 | 389 | 400 | 443 | 455 | 471 | 456 | 511 | 611 | 730 | 882 | 911 | 1,021 |
| OPM % | 32% | 31% | 29% | 29% | 27% | 27% | 26% | 26% | 27% | 26% | 28% | 28% | 29% |
| Other Income | 103 | 24 | 43 | 50 | 25 | 73 | 73 | 83 | 123 | 122 | 94 | 90 | 121 |
| Interest | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 14 | 9 | 6 | 4 | 4 | 19 |
| Depreciation | 38 | 36 | 37 | 55 | 47 | 43 | 37 | 121 | 106 | 103 | 104 | 70 | 114 |
| Profit before tax | 425 | 376 | 406 | 438 | 434 | 500 | 492 | 458 | 618 | 742 | 868 | 926 | 1,009 |
| Tax % | 30% | 29% | 30% | 33% | 30% | 27% | 30% | 23% | 25% | 24% | 24% | 26% | |
| Net Profit | 298 | 268 | 285 | 294 | 304 | 363 | 344 | 355 | 466 | 564 | 658 | 684 | 749 |
| EPS in Rs | 42.16 | 37.62 | 40.04 | 41.26 | 42.46 | 50.35 | 47.57 | 48.87 | 63.92 | 77.25 | 90.06 | 93.54 | 102.45 |
| Dividend Payout % | 45% | 53% | 57% | 65% | 66% | 60% | 67% | 68% | 72% | 62% | 60% | 60% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 13% |
| 3 Years: | 12% |
| TTM: | 6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 16% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 23% |
| 3 Years: | 15% |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 30% |
| 3 Years: | 31% |
| Last Year: | 28% |
Last Updated: September 5, 2025, 2:20 am
Balance Sheet
Last Updated: July 25, 2025, 3:23 pm
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 667 | 841 | 849 | 978 | 1,041 | 1,129 | 1,165 | 1,305 | 1,571 | 1,785 | 2,182 | 2,558 | 2,809 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 0 | 132 | 83 | 47 | 250 | 298 |
| Other Liabilities | 470 | 416 | 475 | 400 | 446 | 495 | 514 | 895 | 793 | 956 | 1,061 | 1,127 | 1,116 |
| Total Liabilities | 1,145 | 1,265 | 1,331 | 1,385 | 1,495 | 1,634 | 1,689 | 2,207 | 2,504 | 2,831 | 3,297 | 3,942 | 4,231 |
| Fixed Assets | 449 | 432 | 413 | 309 | 293 | 350 | 349 | 763 | 661 | 619 | 635 | 976 | 1,085 |
| CWIP | 0 | 0 | 3 | 4 | 13 | 7 | 12 | 14 | 5 | 14 | 31 | 55 | 0 |
| Investments | 244 | 375 | 383 | 465 | 525 | 477 | 453 | 476 | 645 | 683 | 1,056 | 1,454 | 1,390 |
| Other Assets | 451 | 458 | 532 | 607 | 663 | 800 | 875 | 955 | 1,193 | 1,515 | 1,576 | 1,457 | 1,755 |
| Total Assets | 1,145 | 1,265 | 1,331 | 1,385 | 1,495 | 1,634 | 1,689 | 2,207 | 2,504 | 2,831 | 3,297 | 3,942 | 4,231 |
Below is a detailed analysis of the balance sheet data for CRISIL Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Equity Capital, as of Jun 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 7.00 Cr..
- For Reserves, as of Jun 2025, the value is 2,809.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,558.00 Cr. (Dec 2024) to 2,809.00 Cr., marking an increase of 251.00 Cr..
- For Borrowings, as of Jun 2025, the value is 298.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 250.00 Cr. (Dec 2024) to 298.00 Cr., marking an increase of 48.00 Cr..
- For Other Liabilities, as of Jun 2025, the value is 1,116.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,127.00 Cr. (Dec 2024) to 1,116.00 Cr., marking a decrease of 11.00 Cr..
- For Total Liabilities, as of Jun 2025, the value is 4,231.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,942.00 Cr. (Dec 2024) to 4,231.00 Cr., marking an increase of 289.00 Cr..
- For Fixed Assets, as of Jun 2025, the value is 1,085.00 Cr.. The value appears strong and on an upward trend. It has increased from 976.00 Cr. (Dec 2024) to 1,085.00 Cr., marking an increase of 109.00 Cr..
- For CWIP, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 55.00 Cr. (Dec 2024) to 0.00 Cr., marking a decrease of 55.00 Cr..
- For Investments, as of Jun 2025, the value is 1,390.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,454.00 Cr. (Dec 2024) to 1,390.00 Cr., marking a decrease of 64.00 Cr..
- For Other Assets, as of Jun 2025, the value is 1,755.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,457.00 Cr. (Dec 2024) to 1,755.00 Cr., marking an increase of 298.00 Cr..
- For Total Assets, as of Jun 2025, the value is 4,231.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,942.00 Cr. (Dec 2024) to 4,231.00 Cr., marking an increase of 289.00 Cr..
Notably, the Reserves (2,809.00 Cr.) exceed the Borrowings (298.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 361.00 | 389.00 | 400.00 | 443.00 | 455.00 | 468.00 | 453.00 | 511.00 | 479.00 | 647.00 | 835.00 | 661.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 39 | 41 | 52 | 49 | 57 | 59 | 42 | 57 | 86 | 100 | 78 | 62 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 39 | 41 | 52 | 49 | 57 | 59 | 42 | 57 | 86 | 100 | 78 | 62 |
| Working Capital Days | -86 | -46 | -39 | -7 | 2 | -9 | -27 | -35 | -18 | 0 | -7 | -36 |
| ROCE % | 60% | 48% | 45% | 45% | 41% | 45% | 42% | 37% | 38% | 41% | 41% | 36% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Midcap Fund | 1,650,000 | 3.12 | 729.91 | 1,596,679 | 2025-12-15 03:20:02 | 3.34% |
| Kotak Large & Midcap Fund | 625,000 | 0.92 | 276.48 | 612,741 | 2025-12-15 03:20:02 | 2% |
| Quant Multi Cap Fund | 349,522 | 1.76 | 154.62 | N/A | N/A | N/A |
| HSBC Midcap Fund | 294,590 | 1.04 | 130.32 | 375,147 | 2025-12-07 04:01:01 | -21.47% |
| Aditya Birla Sun Life MNC Fund | 185,686 | 2.26 | 82.14 | N/A | N/A | N/A |
| PGIM India Midcap Fund | 165,774 | 0.64 | 73.33 | 173,973 | 2025-12-15 03:20:02 | -4.71% |
| Kotak ELSS Tax Saver Fund | 160,000 | 1.09 | 70.78 | 115,000 | 2025-12-07 09:11:38 | 39.13% |
| Sundaram Mid Cap Fund | 158,014 | 0.52 | 69.9 | N/A | N/A | N/A |
| Sundaram Aggressive Hybrid Fund | 119,934 | 0.69 | 53.06 | N/A | N/A | N/A |
| Mahindra Manulife Multi Cap Fund | 112,400 | 0.81 | 49.72 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 93.55 | 90.08 | 77.31 | 64.03 | 48.93 |
| Diluted EPS (Rs.) | 93.55 | 90.07 | 77.31 | 63.96 | 48.93 |
| Cash EPS (Rs.) | 103.15 | 104.27 | 91.34 | 78.43 | 65.54 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 350.86 | 299.44 | 245.14 | 216.21 | 180.69 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 350.86 | 299.44 | 245.14 | 216.21 | 180.69 |
| Revenue From Operations / Share (Rs.) | 445.93 | 429.48 | 378.76 | 315.60 | 272.98 |
| PBDIT / Share (Rs.) | 136.86 | 133.40 | 116.57 | 94.31 | 81.79 |
| PBIT / Share (Rs.) | 127.29 | 119.20 | 102.44 | 79.77 | 65.11 |
| PBT / Share (Rs.) | 126.74 | 118.70 | 101.56 | 84.83 | 63.13 |
| Net Profit / Share (Rs.) | 93.58 | 90.07 | 77.21 | 63.90 | 48.86 |
| NP After MI And SOA / Share (Rs.) | 93.58 | 90.07 | 77.21 | 63.90 | 48.86 |
| PBDIT Margin (%) | 30.69 | 31.06 | 30.77 | 29.88 | 29.96 |
| PBIT Margin (%) | 28.54 | 27.75 | 27.04 | 25.27 | 23.85 |
| PBT Margin (%) | 28.42 | 27.63 | 26.81 | 26.88 | 23.12 |
| Net Profit Margin (%) | 20.98 | 20.97 | 20.38 | 20.24 | 17.89 |
| NP After MI And SOA Margin (%) | 20.98 | 20.97 | 20.38 | 20.24 | 17.89 |
| Return on Networth / Equity (%) | 26.67 | 30.08 | 31.49 | 29.55 | 27.04 |
| Return on Capital Employeed (%) | 32.64 | 37.75 | 39.67 | 34.16 | 31.14 |
| Return On Assets (%) | 17.35 | 19.86 | 19.93 | 18.60 | 16.07 |
| Asset Turnover Ratio (%) | 0.89 | 1.02 | 1.04 | 0.65 | 0.58 |
| Current Ratio (X) | 1.96 | 2.08 | 1.87 | 1.79 | 1.57 |
| Quick Ratio (X) | 1.96 | 2.08 | 1.87 | 1.79 | 1.57 |
| Dividend Payout Ratio (NP) (%) | 61.99 | 54.39 | 60.79 | 59.35 | 65.41 |
| Dividend Payout Ratio (CP) (%) | 56.24 | 46.98 | 51.39 | 48.35 | 48.76 |
| Earning Retention Ratio (%) | 38.01 | 45.61 | 39.21 | 40.65 | 34.59 |
| Cash Earning Retention Ratio (%) | 43.76 | 53.02 | 48.61 | 51.65 | 51.24 |
| Interest Coverage Ratio (X) | 248.25 | 266.43 | 133.14 | 76.99 | 41.26 |
| Interest Coverage Ratio (Post Tax) (X) | 170.74 | 180.90 | 89.19 | 48.03 | 25.65 |
| Enterprise Value (Cr.) | 48557.78 | 31351.85 | 22093.95 | 20741.31 | 13681.21 |
| EV / Net Operating Revenue (X) | 14.90 | 9.99 | 7.98 | 9.02 | 6.90 |
| EV / EBITDA (X) | 48.54 | 32.15 | 25.93 | 30.17 | 23.04 |
| MarketCap / Net Operating Revenue (X) | 14.99 | 10.10 | 8.10 | 9.14 | 7.04 |
| Retention Ratios (%) | 38.00 | 45.60 | 39.20 | 40.64 | 34.58 |
| Price / BV (X) | 19.05 | 14.49 | 12.51 | 13.35 | 10.64 |
| Price / Net Operating Revenue (X) | 14.99 | 10.10 | 8.10 | 9.14 | 7.04 |
| EarningsYield | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
After reviewing the key financial ratios for CRISIL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Dec 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Dec 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Dec 24, the value is 93.55. This value is within the healthy range. It has increased from 90.08 (Dec 23) to 93.55, marking an increase of 3.47.
- For Diluted EPS (Rs.), as of Dec 24, the value is 93.55. This value is within the healthy range. It has increased from 90.07 (Dec 23) to 93.55, marking an increase of 3.48.
- For Cash EPS (Rs.), as of Dec 24, the value is 103.15. This value is within the healthy range. It has decreased from 104.27 (Dec 23) to 103.15, marking a decrease of 1.12.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 350.86. It has increased from 299.44 (Dec 23) to 350.86, marking an increase of 51.42.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 350.86. It has increased from 299.44 (Dec 23) to 350.86, marking an increase of 51.42.
- For Revenue From Operations / Share (Rs.), as of Dec 24, the value is 445.93. It has increased from 429.48 (Dec 23) to 445.93, marking an increase of 16.45.
- For PBDIT / Share (Rs.), as of Dec 24, the value is 136.86. This value is within the healthy range. It has increased from 133.40 (Dec 23) to 136.86, marking an increase of 3.46.
- For PBIT / Share (Rs.), as of Dec 24, the value is 127.29. This value is within the healthy range. It has increased from 119.20 (Dec 23) to 127.29, marking an increase of 8.09.
- For PBT / Share (Rs.), as of Dec 24, the value is 126.74. This value is within the healthy range. It has increased from 118.70 (Dec 23) to 126.74, marking an increase of 8.04.
- For Net Profit / Share (Rs.), as of Dec 24, the value is 93.58. This value is within the healthy range. It has increased from 90.07 (Dec 23) to 93.58, marking an increase of 3.51.
- For NP After MI And SOA / Share (Rs.), as of Dec 24, the value is 93.58. This value is within the healthy range. It has increased from 90.07 (Dec 23) to 93.58, marking an increase of 3.51.
- For PBDIT Margin (%), as of Dec 24, the value is 30.69. This value is within the healthy range. It has decreased from 31.06 (Dec 23) to 30.69, marking a decrease of 0.37.
- For PBIT Margin (%), as of Dec 24, the value is 28.54. This value exceeds the healthy maximum of 20. It has increased from 27.75 (Dec 23) to 28.54, marking an increase of 0.79.
- For PBT Margin (%), as of Dec 24, the value is 28.42. This value is within the healthy range. It has increased from 27.63 (Dec 23) to 28.42, marking an increase of 0.79.
- For Net Profit Margin (%), as of Dec 24, the value is 20.98. This value exceeds the healthy maximum of 10. It has increased from 20.97 (Dec 23) to 20.98, marking an increase of 0.01.
- For NP After MI And SOA Margin (%), as of Dec 24, the value is 20.98. This value exceeds the healthy maximum of 20. It has increased from 20.97 (Dec 23) to 20.98, marking an increase of 0.01.
- For Return on Networth / Equity (%), as of Dec 24, the value is 26.67. This value is within the healthy range. It has decreased from 30.08 (Dec 23) to 26.67, marking a decrease of 3.41.
- For Return on Capital Employeed (%), as of Dec 24, the value is 32.64. This value is within the healthy range. It has decreased from 37.75 (Dec 23) to 32.64, marking a decrease of 5.11.
- For Return On Assets (%), as of Dec 24, the value is 17.35. This value is within the healthy range. It has decreased from 19.86 (Dec 23) to 17.35, marking a decrease of 2.51.
- For Asset Turnover Ratio (%), as of Dec 24, the value is 0.89. It has decreased from 1.02 (Dec 23) to 0.89, marking a decrease of 0.13.
- For Current Ratio (X), as of Dec 24, the value is 1.96. This value is within the healthy range. It has decreased from 2.08 (Dec 23) to 1.96, marking a decrease of 0.12.
- For Quick Ratio (X), as of Dec 24, the value is 1.96. This value is within the healthy range. It has decreased from 2.08 (Dec 23) to 1.96, marking a decrease of 0.12.
- For Dividend Payout Ratio (NP) (%), as of Dec 24, the value is 61.99. This value exceeds the healthy maximum of 50. It has increased from 54.39 (Dec 23) to 61.99, marking an increase of 7.60.
- For Dividend Payout Ratio (CP) (%), as of Dec 24, the value is 56.24. This value exceeds the healthy maximum of 50. It has increased from 46.98 (Dec 23) to 56.24, marking an increase of 9.26.
- For Earning Retention Ratio (%), as of Dec 24, the value is 38.01. This value is below the healthy minimum of 40. It has decreased from 45.61 (Dec 23) to 38.01, marking a decrease of 7.60.
- For Cash Earning Retention Ratio (%), as of Dec 24, the value is 43.76. This value is within the healthy range. It has decreased from 53.02 (Dec 23) to 43.76, marking a decrease of 9.26.
- For Interest Coverage Ratio (X), as of Dec 24, the value is 248.25. This value is within the healthy range. It has decreased from 266.43 (Dec 23) to 248.25, marking a decrease of 18.18.
- For Interest Coverage Ratio (Post Tax) (X), as of Dec 24, the value is 170.74. This value is within the healthy range. It has decreased from 180.90 (Dec 23) to 170.74, marking a decrease of 10.16.
- For Enterprise Value (Cr.), as of Dec 24, the value is 48,557.78. It has increased from 31,351.85 (Dec 23) to 48,557.78, marking an increase of 17,205.93.
- For EV / Net Operating Revenue (X), as of Dec 24, the value is 14.90. This value exceeds the healthy maximum of 3. It has increased from 9.99 (Dec 23) to 14.90, marking an increase of 4.91.
- For EV / EBITDA (X), as of Dec 24, the value is 48.54. This value exceeds the healthy maximum of 15. It has increased from 32.15 (Dec 23) to 48.54, marking an increase of 16.39.
- For MarketCap / Net Operating Revenue (X), as of Dec 24, the value is 14.99. This value exceeds the healthy maximum of 3. It has increased from 10.10 (Dec 23) to 14.99, marking an increase of 4.89.
- For Retention Ratios (%), as of Dec 24, the value is 38.00. This value is within the healthy range. It has decreased from 45.60 (Dec 23) to 38.00, marking a decrease of 7.60.
- For Price / BV (X), as of Dec 24, the value is 19.05. This value exceeds the healthy maximum of 3. It has increased from 14.49 (Dec 23) to 19.05, marking an increase of 4.56.
- For Price / Net Operating Revenue (X), as of Dec 24, the value is 14.99. This value exceeds the healthy maximum of 3. It has increased from 10.10 (Dec 23) to 14.99, marking an increase of 4.89.
- For EarningsYield, as of Dec 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Dec 23) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CRISIL Ltd:
- Net Profit Margin: 20.98%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 32.64% (Industry Average ROCE: 21.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 26.67% (Industry Average ROE: 19.94%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 170.74
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.96
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 41.9 (Industry average Stock P/E: 38.35)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 20.98%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Services - Others | Lightbridge IT Park, Saki Vihar Road, Mumbai Maharashtra 400072 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Yann Le Pallec | Chairman |
| Mr. Amish Mehta | Managing Director & CEO |
| Mr. Girish Paranjpe | Independent Director |
| Ms. Shyamala Gopinath | Independent Director |
| Mr. Amar Raj Bindra | Independent Director |
| Mr. Nishi Vasudeva | Independent Director |
| Mr. Saugata Saha | Director |
| Mr. Girish Ganesan | Director |
FAQ
What is the intrinsic value of CRISIL Ltd?
CRISIL Ltd's intrinsic value (as of 24 December 2025) is 3608.45 which is 15.91% lower the current market price of 4,291.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 31,390 Cr. market cap, FY2025-2026 high/low of 6,955/3,894, reserves of ₹2,809 Cr, and liabilities of 4,231 Cr.
What is the Market Cap of CRISIL Ltd?
The Market Cap of CRISIL Ltd is 31,390 Cr..
What is the current Stock Price of CRISIL Ltd as on 24 December 2025?
The current stock price of CRISIL Ltd as on 24 December 2025 is 4,291.
What is the High / Low of CRISIL Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CRISIL Ltd stocks is 6,955/3,894.
What is the Stock P/E of CRISIL Ltd?
The Stock P/E of CRISIL Ltd is 41.9.
What is the Book Value of CRISIL Ltd?
The Book Value of CRISIL Ltd is 385.
What is the Dividend Yield of CRISIL Ltd?
The Dividend Yield of CRISIL Ltd is 0.58 %.
What is the ROCE of CRISIL Ltd?
The ROCE of CRISIL Ltd is 35.6 %.
What is the ROE of CRISIL Ltd?
The ROE of CRISIL Ltd is 27.8 %.
What is the Face Value of CRISIL Ltd?
The Face Value of CRISIL Ltd is 1.00.